Back to Agenda
Session 8, Track C: Unveiling the Power and Value of Pharmacovigilance Teams: Pioneering Safety Guardians of the Pharmaceutical World
Session Chair(s)
Vanessa Zapata
Associate Director, Regional Pharmacovigilance Officer
Merck Canada Inc., Canada
Myriam Salem, MSc
Good Pharmacovigilance Practices National Coordinator
Health Canada, Canada
Randy Levitt, PhD
Director, Pharmacovigilance and Medical Affairs
Paladin Pharma Inc., Canada
Unveiling the Power and Value of Pharmacovigilance Teams explores the indispensable role pharmacovigilance has as guardians of patient safety, delving into the trends, challenges, and opportunities shaping this ever-evolving landscape. Renowned experts shed light on cutting-edge strategies and best practices, empowering attendees to navigate complexities with unparalleled expertise. This captivating discourse unveils the invaluable impact of pharmacovigilance teams, fostering a profound appreciation for their pivotal responsibilities in safeguarding public health and ensuring the integrity of pharmaceutical products.
Learning Objective : At the conclusion of this session, participants should be able to:- Analyze the evolving trends, challenges, and opportunities shaping the pharmacovigilance landscape
- Evaluate the invaluable impact of pharmacovigilance teams in safeguarding public health and ensuring regulatory compliance
- Formulate an action plan to elevate the recognition and value of pharmacovigilance departments within organizations
Speaker(s)
Strategies for Demonstrating the Value of Pharmacovigilance
Randy Levitt, PhD
Paladin Pharma Inc., Canada
Director, Pharmacovigilance and Medical Affairs
Pharmacovigilance - Trends, Challenges and Opportunities
Gurpreet Singh
IQVIA, United Kingdom
Vice President, Managing Director Integrated Safety
Collaboration to Reduce Uncertainty in Post-market Drug Safety Analysis
Christopher Gravel, PhD
University of Ottawa (School of Epidemiology and Public Health), Canada
Assistant Professor
Have an account?